SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-22-004443
Filing Date
2022-05-02
Accepted
2022-05-02 16:54:44
Documents
14

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2309941
2 filename2.htm EX-10.23 59245
3 filename3.htm EX-10.24 63381
4 filename4.htm EX-10.25 63164
5 GRAPHIC g241143g01o09.jpg GRAPHIC 172895
6 GRAPHIC g241143g01q92.jpg GRAPHIC 156302
7 GRAPHIC g241143g01w95.jpg GRAPHIC 120391
8 GRAPHIC g241143g05k05.jpg GRAPHIC 212637
9 GRAPHIC g241143g14n05.jpg GRAPHIC 198992
10 GRAPHIC g241143g14n49.jpg GRAPHIC 132118
11 GRAPHIC g241143g14n58.jpg GRAPHIC 94331
12 GRAPHIC g241143g20v78.jpg GRAPHIC 151795
13 GRAPHIC g241143g86c02.jpg GRAPHIC 37470
14 GRAPHIC g241143g92y88.jpg GRAPHIC 173723
  Complete submission text file 0000950123-22-004443.txt   4464638
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-05663 | Film No.: 22882861
SIC: 2836 Biological Products, (No Diagnostic Substances)